Sydney Neuroimaging Analysis Centre

SNAC operates at the intersection of artificial intelligence, healthcare, and medical imaging, with a focused emphasis on brain imaging rather than general-purpose clinical AI. Its described use cases include measuring brain structures and supporting the monitoring of conditions such as multiple sclerosis and dementia. The product set indicates several complementary workflow positions: iQ-Solutions analyzes brain MRI scans, VeriScout™ flags critical abnormalities on brain CT scans for triage, and Torana™ supports secure scan management and routing. The company also offers biomarker development and algorithm integration work, extending beyond standalone software toward clinical and research workflows. Its stated differentiators are a dedicated regulatory-compliant image-analysis facility, clinically validated neuroimaging AI, and federated-learning infrastructure. These details suggest a specialized neuroimaging provider, but do not establish market share or comparative performance.

SNAC was founded in 2012 and has developed a portfolio spanning brain MRI quantification, brain CT triage, scan-management software, biomarker development, and AI integration. Its funding history points to grant-supported development rather than a documented sequence of conventional equity rounds: the known milestones are a A$2.36 million Australian Government CRC-P grant on Jul 31, 2018, a grant dated Jul 1, 2024 associated with MRFF and ANDHealth+, and a CUREator+ grant dated Sep 22, 2025. The company reports an employee range of 11–50, but there is no employee-growth series or hiring announcement to demonstrate expansion. Overall, the evidence supports a long-running, grant-backed specialist operation with a widening product and services scope, while revenue growth, deployment scale, and hiring momentum remain unclear.